Cargando…

Interaction of copper potential metallodrugs with TMPRSS2: A comparative study of docking tools and its implications on COVID-19

SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. For the virus to enter the host cell, its spike (S) protein binds to the ACE2 receptor, and the transmembrane protease serine 2 (TMPRSS2) cleaves the binding for the fusion. As part of the research on COVID-19 treatments, several Casiope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vazquez-Rodriguez, Sergio, Ramírez-Contreras, Diego, Noriega, Lisset, García-García, Amalia, Sánchez-Gaytán, Brenda L., Melendez, Francisco J., Castro, María Eugenia, de Azevedo, Walter Filgueira, González-Vergara, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909424/ https://www.ncbi.nlm.nih.gov/pubmed/36778030 http://dx.doi.org/10.3389/fchem.2023.1128859

Ejemplares similares

Decavanadate Salts of Cytosine and Metformin: A Combined Experimental-Theoretical Study of Potential Metallodrugs Against Diabetes and Cancer
por: Sánchez-Lara, Eduardo, et al.
Publicado: (2018)

Synthesis, Crystal Structure, and Computational Methods of Vanadium and Copper Compounds as Potential Drugs for Cancer Treatment
por: Corona-Motolinia, Nidia D., et al.
Publicado: (2020)

Tris(2-Pyridylmethylamine)V(O)(2) Complexes as Counter Ions of Diprotonated Decavanadate Anion: Potential Antineoplastic Activity
por: Corona-Motolinia, Nidia D., et al.
Publicado: (2022)

New Copper-Based Metallodrugs with Anti-Invasive Capacity
por: Garufi, Alessia, et al.
Publicado: (2023)

Selective Anticancer and Antimicrobial Metallodrugs Based on Gold(III) Dithiocarbamate Complexes
por: Abás, Elisa, et al.
Publicado: (2021)

Target-directed catalytic metallodrugs
por: Joyner, J.C., et al.
Publicado: (2013)

Potent anticancer activity of a novel iridium metallodrug via oncosis
por: Ortega-Forte, Enrique, et al.
Publicado: (2022)

Ruthenacarborane–Phenanthroline Derivatives as Potential Metallodrugs
por: Kellert, Martin, et al.
Publicado: (2020)

Metallodrugs are unique: opportunities and challenges of discovery and development
por: Anthony, Elizabeth J., et al.
Publicado: (2020)

Biological Use of Nanostructured Silica-Based Materials Functionalized with Metallodrugs: The Spanish Perspective
por: Díaz-García, Diana, et al.
Publicado: (2023)

Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment
por: Páez-Franco, José C., et al.
Publicado: (2022)

DNA-Metallodrugs Interactions Signaled by Electrochemical Biosensors: An Overview
por: Ravera, Mauro, et al.
Publicado: (2007)

Metallodrugs: an approach against invasion and metastasis in cancer treatment
por: González‐Ballesteros, Mauricio M., et al.
Publicado: (2022)

Metallodrugs: Mechanisms of Action, Molecular Targets and Biological Activity
por: Ferraro, Giarita, et al.
Publicado: (2022)

Cancer 3D Models for Metallodrug Preclinical Testing
por: Engrácia, Diogo M., et al.
Publicado: (2023)

Multifunctional Silica-Based Nanoparticles with Controlled Release of Organotin Metallodrug for Targeted Theranosis of Breast Cancer
por: Ovejero Paredes, Karina, et al.
Publicado: (2020)

A New MBH Adduct as an Efficient Ligand in the Synthesis of Metallodrugs: Characterization, Geometrical Optimization, XRD, Biological Activities, and Molecular Docking Studies
por: Ishfaq, Shazia, et al.
Publicado: (2022)

Molecular methods for assessment of non-covalent metallodrug–DNA interactions
por: Kellett, Andrew, et al.
Publicado: (2019)

Polyoxometalates as Potential Next‐Generation Metallodrugs in the Combat Against Cancer
por: Bijelic, Aleksandar, et al.
Publicado: (2018)

Cellular Transport Mechanisms of Cytotoxic Metallodrugs: An Overview beyond Cisplatin
por: Spreckelmeyer, Sarah, et al.
Publicado: (2014)

Di-copper metallodrugs promote NCI-60 chemotherapy via singlet oxygen and superoxide production with tandem TA/TA and AT/AT oligonucleotide discrimination
por: Slator, Creina, et al.
Publicado: (2018)

Iron Metallodrugs: Stability, Redox Activity and Toxicity against Artemia salina
por: Vitorino, Hector Aguilar, et al.
Publicado: (2015)

Critical assessment of different methods for quantitative measurement of metallodrug-protein associations
por: Galvez, Luis, et al.
Publicado: (2018)

Expression proteomics study to determine metallodrug targets and optimal drug combinations
por: Lee, Ronald F. S., et al.
Publicado: (2017)

Cellular Basis of Organotin(IV) Derivatives as Anticancer Metallodrugs: A Review
por: Syed Annuar, Sharifah Nadhira, et al.
Publicado: (2021)

Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal Cancer
por: Herrmann, Helena A., et al.
Publicado: (2021)

Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress
por: do Monte, Rubens Lima, et al.
Publicado: (2022)

Beyond Single-Cell Analysis of Metallodrugs by ICP-MS: Targeting Cellular Substructures
por: Galé, Audrey, et al.
Publicado: (2021)

Dynamic Intramolecular Cap for Preserving Metallodrug Integrity—A Case of Catalytic Fluoroquinolones
por: Goldmeier, Moshe N., et al.
Publicado: (2022)

Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey
por: Tolbatov, Iogann, et al.
Publicado: (2021)

Combination of ICP-MS, capillary electrophoresis, and their hyphenation for probing Ru(III) metallodrug–DNA interactions
por: Foteeva, Lidia S., et al.
Publicado: (2017)

Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug
por: Miller, Maya, et al.
Publicado: (2020)

Surmounting tumor resistance to metallodrugs by co-loading a metal complex and siRNA in nanoparticles
por: Qiao, Hongzhi, et al.
Publicado: (2021)

Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes
por: Kazimir, Aleksandr, et al.
Publicado: (2023)

Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug
por: Ugalde-Arbizu, Maider, et al.
Publicado: (2023)

Rapid screening of photoactivatable metallodrugs: photonic crystal fibre microflow reactor coupled to ESI mass spectrometry
por: McQuitty, Ruth J., et al.
Publicado: (2017)

Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?
por: Abbadi, Bruno L., et al.
Publicado: (2018)

Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens
por: Su, Yan, et al.
Publicado: (2022)

Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin Adduct
por: Monti, Daria Maria, et al.
Publicado: (2022)

Metallodrugs in the battle against non-small cell lung cancer: unlocking the potential for improved therapeutic outcomes
por: Xu, Xianzhi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k0u0ukhlgfeij0m6g74jrdqt1s